Showing results (1291-1300 of 2,457) with videos related to
Sort By:
Pageof 246
Archives of Internal Medicine|September 9, 1996
Advance directives in Utah. Information from death certificates and informantsJ A Jacobson, E Kasworm, M P Battin, et al.Biochemical Pharmacology|March 8, 2003
Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptorsSeong G Kim, Kelly A Soltysiak, Zhan-Guo Gao, et al.Chest|February 1, 1989
Prospective study of a standardized questionnaire to improve clinical estimate of pulmonary embolismA Celi, A Palla, S Petruzzelli, et al.Cancer Gene Therapy|January 10, 2019
JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer modelsManish R Patel, Alexander Dash, Blake A Jacobson, et al.Experimental Eye Research|May 11, 2007
Barrier qualities of the mouse eye to topically applied drugsZhao Wang, Chi Wai Do, Marcel Y Avila, et al.International Immunology|June 9, 2004
Tumor cells secreting IL-13 but not IL-13Ralpha2 fusion protein have reduced tumorigenicity in vivoHak-Ling Ma, Matthew J Whitters, Bruce A Jacobson, et al.Journal of Medicinal Chemistry|March 18, 2005
(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonistsSusanna Tchilibon, Bhalchandra V Joshi, Soo-Kyung Kim, et al.The Journal of Pharmacology and Experimental Therapeutics|September 4, 2004
Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analogMariya Chhatriwala, R Gnana Ravi, Roshni I Patel, et al.British Journal of Clinical Pharmacology|June 16, 2011
Dosing equation for tacrolimus using genetic variants and clinical factorsChaitali Passey, Angela K Birnbaum, Richard C Brundage, et al.Biochemical Pharmacology|July 2, 2011
Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancersZhan-Guo Gao, Dennis Verzijl, Annelien Zweemer, et al.Pageof 246